From: Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Cytokine/ Chemokine/ Growth factor | Mean concentration (pg/mL) ± SEM | Serum-free medium (pg/mL) | n (%) of PitNETs with detectable cytokine |
---|---|---|---|
IL-8 | 854.18 ± 445.79 | 7.06 | 22 (91.7%) |
CCL2 | 578.03 ± 222.66 | 4.00 | 21 (87.5%) |
CCL3 | 150.55 ± 88.22 | 0 | 22 (91.7%) |
CCL4 | 94.25 ± 47.20 | 3.09 | 18 (75.0%) |
CXCL10 | 76.67 ± 47.58 | 0 | 14 (58.3%) |
CCL22 | 67.25 ± 16.74 | 20.78 | 15 (62.5%) |
CXCL1 | 60.30 ± 26.14 | 20.78 | 12 (50.0%) |
CX3CL1 | 35.14 ± 17.12 | 6.73 | 19 (79.2%) |
FGF-2 | 26.65 ± 4.11 | 0 | 19 (79.2%) |
IL-6 | 24.90 ± 19.27 | 0 | 12 (50.0%) |
PDGF-AA | 22.36 ± 6.78 | 0.12 | 20 (83.3%) |
VEGF-A | 15.85 ± 4.06 | 0 | 18 (75.0%) |